HK Stock MarketDetailed Quotes

06667 MEGA GENOMICS

Watchlist

10.680
+0.700+7.01%

Market Closed May 3 16:09 CST

2.53BMarket Cap76.29P/E (TTM)

MEGA GENOMICS Key Stats

Cash Flow

All

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q9)Sep 30, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

(Q9)Sep 30, 2020

(Q6)Jun 30, 2020

Cash flow from operating activities

Earning before tax

268.92%36.18M

103.56%42.3M

-122.34%-21.42M

-51.10%20.78M

1.03%95.88M

-17.82%51.44M

5.14%42.49M

147.84%94.9M

--62.6M

--40.42M

Profit adjustment

Interest (income) - adjustment

47.91%-722K

54.48%-361K

-415.24%-1.39M

-487.41%-793K

21.80%-269K

30.34%-163K

-7.14%-135K

-882.86%-344K

---234K

---126K

Interest expense - adjustment

----

-58.33%6.13M

-44.44%6.13M

-16.67%6.13M

-11.09%14.7M

--11.03M

--7.35M

Investment loss (gain)

-103.47%-5.34M

-179.69%-2.51M

3.03%-2.63M

28.78%-896K

---2.71M

---1.32M

---1.26M

----

Impairment and provisions:

-144.79%-11.58M

-5,228.57%-10.41M

319.33%25.85M

-79.33%203K

949.17%6.17M

-14.55%8.46M

-84.11%982K

-111.25%-726K

--9.9M

--6.18M

-Impairment of trade receivables (reversal)

-154.06%-13.98M

-5,228.57%-10.41M

319.33%25.85M

-79.33%203K

949.17%6.17M

-14.55%8.46M

-84.11%982K

-111.25%-726K

--9.9M

--6.18M

-Other impairments and provisions

--2.4M

----

Revaluation surplus:

152.94%430K

--0

393.10%170K

--0

42.00%-58K

-619.00%-719K

---400K

---100K

--0

-Other fair value changes

152.94%430K

----

393.10%170K

----

42.00%-58K

-619.00%-719K

---400K

---100K

----

Asset sale loss (gain):

--0

Depreciation and amortization:

-1.03%15.12M

-2.24%7.58M

10.13%15.28M

11.90%7.76M

-1.16%13.87M

-1.07%10.4M

-1.06%6.93M

-0.13%14.04M

--10.51M

--7.01M

-Depreciation

-1.02%14.97M

-2.24%7.51M

9.82%15.12M

11.56%7.68M

-1.26%13.77M

-1.07%10.33M

-1.06%6.89M

-0.30%13.94M

--10.45M

--6.96M

-Amortization of intangible assets

-2.52%155K

-2.67%73K

50.00%159K

63.04%75K

13.98%106K

0.00%69K

0.00%46K

34.78%93K

--69K

--46K

Financial expense

56.05%1.12M

-34.48%266K

-8.41%719K

-11.55%406K

-57.59%785K

-58.02%631K

-57.46%459K

-39.35%1.85M

--1.5M

--1.08M

Exchange Loss (gain)

87.75%-1.44M

-394.12%-1.34M

-1,421.60%-11.75M

---272K

--889K

--673K

----

Special items

59.73%6.69M

826.36%3.33M

447.76%4.19M

-53.00%-459K

-100.67%-1.2M

0.00%-450K

---300K

0.00%-600K

---450K

----

Operating profit before the change of operating capital

348.17%40.46M

45.41%38.86M

-92.44%9.03M

-51.32%26.73M

-3.43%119.48M

-20.76%75.08M

-11.32%54.9M

59.13%123.72M

--94.76M

--61.91M

Change of operating capital

Inventory (increase) decrease

-302.23%-901K

129.39%261K

28.21%-224K

-228.89%-888K

41.35%-312K

-17.54%-563K

79.04%-270K

-199.25%-532K

---479K

---1.29M

Accounts receivable (increase)decrease

1,277.02%82.92M

140.15%21.35M

91.15%-7.05M

-0.41%-53.16M

-272.08%-79.56M

-54.27%-92.12M

6.94%-52.95M

-5.55%-21.38M

---59.71M

---56.89M

Accounts payable increase (decrease)

1,900.14%42.06M

59.94%8.1M

-79.20%2.1M

1,487.15%5.06M

-3.96%10.11M

-124.34%-5.09M

-98.49%319K

144.59%10.53M

--20.89M

--21.1M

prepayments (increase)decrease

357.95%2.32M

-127.94%-589K

89.71%-899K

148.99%2.11M

-368.81%-8.74M

10.41%-9.9M

-184.13%-4.3M

-18.66%3.25M

---11.05M

--5.12M

Cash from business operations

5,533.29%166.86M

437.30%67.98M

-92.77%2.96M

-775.50%-20.15M

-64.55%40.98M

-173.37%-32.58M

-107.77%-2.3M

186.43%115.59M

--44.41M

--29.63M

Other taxs

65.40%-3.9M

87.22%-1.02M

-6.02%-11.26M

-60.27%-7.96M

18.89%-10.62M

-21.17%-10M

-332.96%-4.97M

-320.05%-13.09M

---8.25M

---1.15M

Interest received - operating

-47.91%722K

-54.48%361K

415.24%1.39M

487.41%793K

-21.80%269K

-30.34%163K

7.14%135K

882.86%344K

--234K

--126K

Special items of business

----

---300K

Net cash from operations

2,468.46%163.68M

346.42%67.32M

-122.56%-6.91M

-283.01%-27.32M

-70.22%30.63M

-216.57%-42.42M

-124.93%-7.13M

175.91%102.84M

--36.39M

--28.61M

Cash flow from investment activities

Purchase of fixed assets

-616.28%-35.86M

-1,443.73%-12.67M

-20.37%-5.01M

40.07%-821K

-297.99%-4.16M

-444.44%-1.67M

21.76%-1.37M

-79.86%-1.05M

---306K

---1.75M

Purchase of intangible assets

-31.87%-240K

48.91%-70K

30.80%-182K

---137K

---263K

----

Recovery of cash from investments

-54.31%483.62M

55.95%560.21M

92.92%1.06B

5.88%359.22M

--548.71M

--367.82M

--339.26M

----

Cash on investment

54.42%-481.28M

-57.88%-565.7M

-93.39%-1.06B

-6.01%-358.32M

-1,717.46%-546M

---338M

---30.04M

----

Net cash from investment operations

-1,217.49%-33.75M

-29,316.13%-18.24M

-49.47%-2.56M

44.64%-62K

94.49%-1.71M

-492.61%-179.85M

93.60%-112K

-275.95%-31.09M

---30.35M

---1.75M

Net cash before financing

1,471.58%129.93M

279.26%49.09M

-132.76%-9.47M

-277.94%-27.38M

-59.70%28.92M

-3,778.07%-222.27M

-126.97%-7.25M

30.60%71.75M

--6.04M

--26.86M

Cash flow from financing activities

New borrowing

--23.56M

----

Refund

---925K

----

74.50%-2.65M

65.88%-2.65M

48.64%-2.65M

-2.70%-10.41M

---7.78M

---5.17M

Issuing shares

----

-19.52%184.16M

--228.82M

----

Interest paid - financing

-56.05%-1.12M

34.48%-266K

8.41%-719K

11.55%-406K

57.59%-785K

58.02%-631K

57.46%-459K

39.35%-1.85M

---1.5M

---1.08M

Absorb investment income

----

--100M

--92M

Issuance expenses and redemption of securities expenses

40.56%-10.5M

----

-2,477.66%-17.66M

---18.32M

---685K

----

Other items of the financing business

-226.89%-23.93M

-949.05%-19.33M

96.70%-7.32M

99.01%-1.84M

-5,921.50%-222.07M

-5,719.92%-190.49M

-10,222.07%-186.62M

48.02%-3.69M

---3.27M

---1.81M

Adjustment item of financing business

----

---2.17M

----

Net cash from financing operations

-108.15%-12.91M

-111.98%-19.6M

5,948.05%158.46M

318.57%163.58M

-96.88%2.62M

-62.41%32.87M

-53.45%39.08M

514.49%84.06M

--87.45M

--83.95M

Effect of rate

-87.75%1.44M

394.12%1.34M

1,421.60%11.75M

--272K

---889K

---673K

----

Net Cash

-21.46%117.02M

-78.35%29.49M

372.45%148.99M

327.82%136.2M

-79.76%31.54M

-302.58%-189.39M

-71.27%31.84M

349.51%155.8M

--93.49M

--110.81M

Begining period cash

67.23%399.83M

14.70%239.1M

295.95%208.45M

192.72%52.65M

--52.65M

Cash at the end

29.63%518.29M

14.67%430.66M

67.23%399.83M

56.30%375.57M

14.70%239.1M

-87.42%18.39M

47.01%240.29M

295.95%208.45M

--146.13M

--163.45M

Cash balance analysis

Cash and bank balance

----

-87.42%18.39M

----

--146.13M

--163.45M

Cash and cash equivalent balance

--0

-87.42%18.39M

--0

--146.13M

--163.45M

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

Ernst & Young

	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q9)Sep 30, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020	(Q9)Sep 30, 2020	(Q6)Jun 30, 2020
Cash flow from operating activities
Earning before tax	268.92%36.18M	103.56%42.3M	-122.34%-21.42M	-51.10%20.78M	1.03%95.88M	-17.82%51.44M	5.14%42.49M	147.84%94.9M	--62.6M	--40.42M
Profit adjustment
Interest (income) - adjustment	47.91%-722K	54.48%-361K	-415.24%-1.39M	-487.41%-793K	21.80%-269K	30.34%-163K	-7.14%-135K	-882.86%-344K	---234K	---126K
Interest expense - adjustment	----	----	----	----	-58.33%6.13M	-44.44%6.13M	-16.67%6.13M	-11.09%14.7M	--11.03M	--7.35M
Investment loss (gain)	-103.47%-5.34M	-179.69%-2.51M	3.03%-2.63M	28.78%-896K	---2.71M	---1.32M	---1.26M	----	----	----
Impairment and provisions:	-144.79%-11.58M	-5,228.57%-10.41M	319.33%25.85M	-79.33%203K	949.17%6.17M	-14.55%8.46M	-84.11%982K	-111.25%-726K	--9.9M	--6.18M
-Impairment of trade receivables (reversal)	-154.06%-13.98M	-5,228.57%-10.41M	319.33%25.85M	-79.33%203K	949.17%6.17M	-14.55%8.46M	-84.11%982K	-111.25%-726K	--9.9M	--6.18M
-Other impairments and provisions	--2.4M	----	----	----	----	----	----	----	----	----
Revaluation surplus:	152.94%430K	--0	393.10%170K	--0	42.00%-58K	-619.00%-719K	---400K	---100K	---100K	--0
-Other fair value changes	152.94%430K	----	393.10%170K	----	42.00%-58K	-619.00%-719K	---400K	---100K	---100K	----
Asset sale loss (gain):	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Depreciation and amortization:	-1.03%15.12M	-2.24%7.58M	10.13%15.28M	11.90%7.76M	-1.16%13.87M	-1.07%10.4M	-1.06%6.93M	-0.13%14.04M	--10.51M	--7.01M
-Depreciation	-1.02%14.97M	-2.24%7.51M	9.82%15.12M	11.56%7.68M	-1.26%13.77M	-1.07%10.33M	-1.06%6.89M	-0.30%13.94M	--10.45M	--6.96M
-Amortization of intangible assets	-2.52%155K	-2.67%73K	50.00%159K	63.04%75K	13.98%106K	0.00%69K	0.00%46K	34.78%93K	--69K	--46K
Financial expense	56.05%1.12M	-34.48%266K	-8.41%719K	-11.55%406K	-57.59%785K	-58.02%631K	-57.46%459K	-39.35%1.85M	--1.5M	--1.08M
Exchange Loss (gain)	87.75%-1.44M	-394.12%-1.34M	-1,421.60%-11.75M	---272K	--889K	--673K	----	----	----	----
Special items	59.73%6.69M	826.36%3.33M	447.76%4.19M	-53.00%-459K	-100.67%-1.2M	0.00%-450K	---300K	0.00%-600K	---450K	----
Operating profit before the change of operating capital	348.17%40.46M	45.41%38.86M	-92.44%9.03M	-51.32%26.73M	-3.43%119.48M	-20.76%75.08M	-11.32%54.9M	59.13%123.72M	--94.76M	--61.91M
Change of operating capital
Inventory (increase) decrease	-302.23%-901K	129.39%261K	28.21%-224K	-228.89%-888K	41.35%-312K	-17.54%-563K	79.04%-270K	-199.25%-532K	---479K	---1.29M
Accounts receivable (increase)decrease	1,277.02%82.92M	140.15%21.35M	91.15%-7.05M	-0.41%-53.16M	-272.08%-79.56M	-54.27%-92.12M	6.94%-52.95M	-5.55%-21.38M	---59.71M	---56.89M
Accounts payable increase (decrease)	1,900.14%42.06M	59.94%8.1M	-79.20%2.1M	1,487.15%5.06M	-3.96%10.11M	-124.34%-5.09M	-98.49%319K	144.59%10.53M	--20.89M	--21.1M
prepayments (increase)decrease	357.95%2.32M	-127.94%-589K	89.71%-899K	148.99%2.11M	-368.81%-8.74M	10.41%-9.9M	-184.13%-4.3M	-18.66%3.25M	---11.05M	--5.12M
Cash from business operations	5,533.29%166.86M	437.30%67.98M	-92.77%2.96M	-775.50%-20.15M	-64.55%40.98M	-173.37%-32.58M	-107.77%-2.3M	186.43%115.59M	--44.41M	--29.63M
Other taxs	65.40%-3.9M	87.22%-1.02M	-6.02%-11.26M	-60.27%-7.96M	18.89%-10.62M	-21.17%-10M	-332.96%-4.97M	-320.05%-13.09M	---8.25M	---1.15M
Interest received - operating	-47.91%722K	-54.48%361K	415.24%1.39M	487.41%793K	-21.80%269K	-30.34%163K	7.14%135K	882.86%344K	--234K	--126K
Special items of business	----	----	----	----	----	----	----	----	----	---300K
Net cash from operations	2,468.46%163.68M	346.42%67.32M	-122.56%-6.91M	-283.01%-27.32M	-70.22%30.63M	-216.57%-42.42M	-124.93%-7.13M	175.91%102.84M	--36.39M	--28.61M
Cash flow from investment activities
Purchase of fixed assets	-616.28%-35.86M	-1,443.73%-12.67M	-20.37%-5.01M	40.07%-821K	-297.99%-4.16M	-444.44%-1.67M	21.76%-1.37M	-79.86%-1.05M	---306K	---1.75M
Purchase of intangible assets	-31.87%-240K	48.91%-70K	30.80%-182K	---137K	---263K	----	----	----	----	----
Recovery of cash from investments	-54.31%483.62M	55.95%560.21M	92.92%1.06B	5.88%359.22M	--548.71M	--367.82M	--339.26M	----	----	----
Cash on investment	54.42%-481.28M	-57.88%-565.7M	-93.39%-1.06B	-6.01%-358.32M	-1,717.46%-546M	-1,717.46%-546M	---338M	---30.04M	---30.04M	----
Net cash from investment operations	-1,217.49%-33.75M	-29,316.13%-18.24M	-49.47%-2.56M	44.64%-62K	94.49%-1.71M	-492.61%-179.85M	93.60%-112K	-275.95%-31.09M	---30.35M	---1.75M
Net cash before financing	1,471.58%129.93M	279.26%49.09M	-132.76%-9.47M	-277.94%-27.38M	-59.70%28.92M	-3,778.07%-222.27M	-126.97%-7.25M	30.60%71.75M	--6.04M	--26.86M
Cash flow from financing activities
New borrowing	--23.56M	----	----	----	----	----	----	----	----	----
Refund	---925K	----	----	----	74.50%-2.65M	65.88%-2.65M	48.64%-2.65M	-2.70%-10.41M	---7.78M	---5.17M
Issuing shares	----	----	-19.52%184.16M	-19.52%184.16M	--228.82M	--228.82M	--228.82M	----	----	----
Interest paid - financing	-56.05%-1.12M	34.48%-266K	8.41%-719K	11.55%-406K	57.59%-785K	58.02%-631K	57.46%-459K	39.35%-1.85M	---1.5M	---1.08M
Absorb investment income	----	----	----	----	----	----	----	--100M	--100M	--92M
Issuance expenses and redemption of securities expenses	40.56%-10.5M	----	-2,477.66%-17.66M	---18.32M	---685K	----	----	----	----	----
Other items of the financing business	-226.89%-23.93M	-949.05%-19.33M	96.70%-7.32M	99.01%-1.84M	-5,921.50%-222.07M	-5,719.92%-190.49M	-10,222.07%-186.62M	48.02%-3.69M	---3.27M	---1.81M
Adjustment item of financing business	----	----	----	----	----	---2.17M	----	----	----	----
Net cash from financing operations	-108.15%-12.91M	-111.98%-19.6M	5,948.05%158.46M	318.57%163.58M	-96.88%2.62M	-62.41%32.87M	-53.45%39.08M	514.49%84.06M	--87.45M	--83.95M
Effect of rate	-87.75%1.44M	394.12%1.34M	1,421.60%11.75M	--272K	---889K	---673K	----	----	----	----
Net Cash	-21.46%117.02M	-78.35%29.49M	372.45%148.99M	327.82%136.2M	-79.76%31.54M	-302.58%-189.39M	-71.27%31.84M	349.51%155.8M	--93.49M	--110.81M
Begining period cash	67.23%399.83M	67.23%399.83M	14.70%239.1M	14.70%239.1M	295.95%208.45M	295.95%208.45M	295.95%208.45M	192.72%52.65M	--52.65M	--52.65M
Cash at the end	29.63%518.29M	14.67%430.66M	67.23%399.83M	56.30%375.57M	14.70%239.1M	-87.42%18.39M	47.01%240.29M	295.95%208.45M	--146.13M	--163.45M
Cash balance analysis
Cash and bank balance	----	----	----	----	----	-87.42%18.39M	----	----	--146.13M	--163.45M
Cash and cash equivalent balance	--0	--0	--0	--0	--0	-87.42%18.39M	--0	--0	--146.13M	--163.45M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	--	Unqualified Opinion	--	--
Auditor	Ernst & Young	--	Ernst & Young	--	Ernst & Young	--	--	Ernst & Young	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

06667 MEGA GENOMICS

MEGA GENOMICS Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target